6-Keto PGExi A Possible Metabolite of Prostacyclin Having Platelet Antiaggregatory Effects
نویسنده
چکیده
Hepatic metabolism of prostacydin (PGI,) results in the formation of several biologically inactive lipids and one stable product that has the same chromatographic and biological properties as authentic 6-keto PGE,. Both prostaglandins, 6-keto PGE, and PGI2, hare comparable potency in their antiaggregatory and disaggregatory effects on platelets. They contract the superfused rat stomach strip but differ in their effects on the bovine coronary artery, which is contracted by 6-keto PGE, but relaxed by PGI2. Further, 6-keto PGE, is considerably more stable than PGI,. Thus, 6-keto PGE, could account for some of the prolonged effects occasionally seen with PGI,. (Hypertension 2: 524-528, 1980)
منابع مشابه
6-keto PGE1: a possible metabolite of prostacyclin having platelet antiaggregatory effects.
Hepatic metabolism of prostacyclin (PGI2) results in the formation of several biologically inactive lipids and one stable product that has the same chromatographic and biological properties as authentic 6-keto PGE1. Both prostaglandins, 6-keto PGE1 and PGI2, have comparable potency in their antiaggregatory and disaggregatory effects on platelets. They contract the superfused rat stomach strip b...
متن کاملProstacyclin and thromboxane in diabetes.
Concentrations of the stable antiaggregatory prostacyclin metabolite 6-keto-prostaglandin F1 alpha (6-keto-PGF1 alpha) and of the proaggregatory thromboxane A2 metabolite thromboxane B2 were measured by radioimmunoassay in plasma from 53 diabetics. In 33 of these patients the ability of platelets to produce thromboxane B2 during spontaneous clotting was also studied. Plasma 6-keto-PGF1 alpha co...
متن کاملEnhancement of the antiaggregatory activity of prostacyclin by propranolol in human platelets.
The beta-adrenergic antagonist propranolol has been found to inhibit platelet aggregation. We investigated the possibility that propranolol exerts this action by stimulating the synthesis or enhancing the antiaggregatory activity of prostaglandin (PG) I2. The media from cultures of human endothelial cells inhibited thrombin-induced platelet aggregation, an effect attributed to PGI2 production b...
متن کاملComparative effects of immediate-release and extended-release aspirin on basal and bradykinin-stimulated excretion of thromboxane and prostacyclin metabolites.
A goal of aspirin therapy is to inhibit thromboxane production and platelet aggregation without inhibiting endothelial production of the vasodilator and anti-thrombotic prostacyclin. This study tested the hypothesis that extended-release aspirin (NHP-554C) would have increased selectivity for inhibition of basal and simulated thromboxane formation compared to immediate-release aspirin (ASA). Th...
متن کاملTHERAPY AND PREVENTION PIHARMACOLOGY The effects of organic nitrates on prostacyclin biosynthesis and platelet function in humans
The results of prior studies indicate that nitroglycerin stimulates prostacyclin release by cultured endothelium and by the coronary vasculature in vivo. However, the accuracy of these findings in coronary vasculature relies on plasma samples obtained from the circulation via cardiac catheters, a procedure we have shown to stimulate prostacyclin release, thereby confounding'interpretation of dr...
متن کامل